Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

GUD

Knight Therapeutics (GUD)

Knight Therapeutics Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:GUD

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
10/08/2023	17h00	AllPennyStocks.com	Trading For This Specialty Pharma Company is up Following Second Quarter Results	TSX:GUD	Knight Therapeutics Inc
13/05/2021	15h38	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - GUD	TSX:GUD	Knight Therapeutics Inc
13/05/2021	15h37	PR Newswire (Canada)	IIROC Trade Resumption - GUD	TSX:GUD	Knight Therapeutics Inc
13/05/2021	14h25	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - GUD	TSX:GUD	Knight Therapeutics Inc
13/05/2021	14h24	PR Newswire (Canada)	IIROC Trading Halt - GUD	TSX:GUD	Knight Therapeutics Inc
03/05/2021	12h00	PR Newswire (Canada)	Maverix Private Equity Announces Team Additions	TSX:GUD	Knight Therapeutics Inc
03/05/2021	12h00	PR Newswire (US)	Maverix Private Equity Announces Team Additions	TSX:GUD	Knight Therapeutics Inc
11/12/2020	23h15	PR Newswire (Canada)	S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index	TSX:GUD	Knight Therapeutics Inc
11/12/2020	23h15	PR Newswire (Canada)	S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX	TSX:GUD	Knight Therapeutics Inc
08/01/2020	14h00	PR Newswire (US)	Knight Partners With Debiopharm for the Commercialization of Trelstar® in Canada	TSX:GUD	Knight Therapeutics Inc
18/06/2019	23h00	PR Newswire (US)	Medimetriks Pharmaceuticals Focuses on Advancing MM36 (difamilast) Through Phase 3 Trials; Extinguishes Debt Owed to Knight T...	TSX:GUD	Knight Therapeutics Inc
29/04/2019	14h45	PR Newswire (Canada)	Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Q...	TSX:GUD	Knight Therapeutics Inc
25/04/2019	16h21	PR Newswire (Canada)	Leading Independent Proxy Advisory Firm ISS Recommends Change at Knight Therapeutics	TSX:GUD	Knight Therapeutics Inc
18/04/2019	15h00	PR Newswire (Canada)	Medison Issues Presentation to Knight Shareholders	TSX:GUD	Knight Therapeutics Inc
17/04/2019	13h00	PR Newswire (Canada)	Leading Canadian Corporate Governance Expert Confirms Acute Board Conflicts and Governance Deficiencies at Knight Therapeutic...	TSX:GUD	Knight Therapeutics Inc
16/04/2019	14h30	PR Newswire (Canada)	Medison Issues Letter to Shareholders of Knight Therapeutics, Outlining Qualified, Independent Director Nominees and Common-S...	TSX:GUD	Knight Therapeutics Inc
10/04/2019	14h39	PR Newswire (Canada)	Medison Disappointed that Knight Therapeutics has Resorted to Blatant Misrepresentations to Avoid Scrutiny	TSX:GUD	Knight Therapeutics Inc
08/04/2019	14h00	PR Newswire (Canada)	Medison Files Proxy Circular, Offers Knight Therapeutics Shareholders Truly Independent, Unconflicted Directors and Comprehen...	TSX:GUD	Knight Therapeutics Inc
01/04/2019	14h00	PR Newswire (Canada)	Medison to Nominate Six Highly Qualified Directors for Knight Therapeutics' Board to Strengthen Oversight and Drive Value Cre...	TSX:GUD	Knight Therapeutics Inc
18/02/2019	14h30	PR Newswire (US)	Knight Signs GUD (Bueno) Latin American Strategic Funding Deal with Moksha8	TSX:GUD	Knight Therapeutics Inc
19/03/2018	11h30	PR Newswire (US)	Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada	TSX:GUD	Knight Therapeutics Inc
08/02/2018	15h21	PR Newswire (US)	60° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria Drug	TSX:GUD	Knight Therapeutics Inc
08/02/2018	15h03	PR Newswire (US)	60° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria Drug	TSX:GUD	Knight Therapeutics Inc
04/01/2018	15h45	PR Newswire (US)	60 Degrees Pharmaceuticals Fast Tracked For Malaria Drug	TSX:GUD	Knight Therapeutics Inc
18/12/2017	15h00	PR Newswire (US)	60° Pharmaceuticals (60P) Submits New Drug Application to US FDA for Antimalarial Drug Tafenoquine	TSX:GUD	Knight Therapeutics Inc
14/08/2017	23h30	Marketwired	Synergy CHC Corp. Announces Second Quarter 2017 Results	TSX:GUD	Knight Therapeutics Inc
13/06/2017	14h03	PR Newswire (Canada)	Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid...	TSX:GUD	Knight Therapeutics Inc
13/06/2017	14h03	PR Newswire (US)	Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid...	TSX:GUD	Knight Therapeutics Inc
10/12/2016	00h17	PR Newswire (Canada)	Indices S&P Dow Jones annonce des modifications à certains indices canadiens S&P/TSX	TSX:GUD	Knight Therapeutics Inc
22/03/2016	12h59	PR Newswire (US)	Profounda, Inc. launches Impavido® (miltefosine), the first and only oral Rx treatment for visceral, mucosal and cutaneous l...	TSX:GUD	Knight Therapeutics Inc

Showing the most relevant articles for your search:TSX:GUD

Gold vs US Dollar

Euro vs Sterling

Deutsche Telekom (QX)

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen